Answer
Pegcetacoplan’s median effective elimination half-life in patients with PNH is 8.6 days following multiple subcutaneous doses, as estimated by population pharmacokinetic analysis.
Sources for this answer
- ASPAVELI 1080 mg solution for infusionSwedish Orphan Biovitrum Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 12Document updated
Sources checked